Ecological Dynamics and Functional Classification of Nanosynbacter lyticus Strain TM7x in the Human Oral Microbiome: A Literature Review

1. Introduction

Nanosymbacter lyticus TM7x is the first cultivated member of the phylum Saccharibacteria, part of the Candidate Phylum Radiation (CPR)—now recognized as the superphylum Patescibacteria—a vast and genetically diverse monophyletic group estimated to account for over 25% of all bacterial diversity [1,2]. These organisms are characterized by an epibiotic lifestyle, ultra-small cell sizes (200–500 nm), and highly reduced genomes lacking most essential biosynthetic pathways [2]. For TM7x, its biological existence is fundamentally defined by its dependence on a host from the genus Actinomyces, specifically Schaalia odontolytica strain XH001 [3]. Whether this relationship is inherently deleterious (epipatobiont) or provides compensatory benefits that preserve oral health (episymbiont) remains a central question in the field. This inquiry is underscored by evidence suggesting that Saccharibacteria (TM7) may contribute to periodontal pathogenesis [1,4,5,6]. Consequently, this structured review synthesizes primary evidence from the past decade to define the ecological role of N. lyticus TM7x within the oral ecosystem.

2. Methodology

2.1. Search Strategy and Selection Criteria

A systematic search was conducted to identify primary studies regarding the physiology, genomics, and ecological interactions of Nanosynbacter lyticus strain TM7x. The PubMed, Scopus, and Embase databases were queried for literature published between 2015 (marking the initial isolation of TM7x) and 2025.

Inclusion criteria encompassed: (i) studies utilizing the cultivated strain TM7x or its specific host (S. odontolytica XH001); (ii) molecular or transcriptomic analyses of the host-epibiont relationship; (iii) clinical studies correlating Saccharibacteria abundance with human oral health or disease parameters; and (iv) functional assays involving animal models or human cell cultures.

Exclusion criteria were applied to studies solely reporting 16S-rRNA diversity profiles without functional analysis, as well as articles focused exclusively on environmental Saccharibacteria unrelated to the human microbiome.

2.2. Review Workflow and Data Synthesis

The selection process followed a structured workflow:

• Identification: 351 records were initially identified through database searches.
• Screening: 165 unique entries remained after deduplication and title/abstract screening for thematic relevance.
• Eligibility: 44 full-text articles were rigorously assessed for functional or experimental data on TM7x.
• Inclusion: 28 key articles were selected for qualitative synthesis, covering topics from comparative genomics to in vivo immunomodulation (Table 1).

Data extraction and visualization were performed using Microsoft Excel and PowerPoint (v. 2021).

Generative AI (Gemini 2.5 Flash, Google) was utilized as a computational tool to assist in the conceptual design and drafting of Figure 1 and the Graphical Abstract.

3. Results

3.1. Genomic Architecture and Metabolic Constraints of Strain TM7x

The ability of Nanosymbacter lyticus TM7x to persist within the oral microbiome, despite severe genetic deficiencies, underscores its extreme evolutionary specialization. Its genome (~700 kb) is among the smallest recorded for an extracellular bacterium. This genomic reduction has led to the loss of core biosynthetic pathways for amino acids, lipids, vitamins, and cell wall precursors [7].

TM7x is nearly entirely auxotrophic; genomic analysis indicates it cannot synthesize any of the 20 essential amino acids de novo, nor the vitamin cofactors required for most enzymatic functions. In contrast to its host, S. odontolytica XH001—which possesses over 123 functional metabolic pathways—TM7x operates with a minimal repertoire of only 20 pathways and approximately 151 identified chemical reactions. This metabolic disparity necessitates intimate physical contact; TM7x must "harvest" molecular building blocks directly from the host's surface or cytoplasm via specialized transporters highly expressed during stable symbiosis [8,9].

Despite this minimalism, TM7x selectively retains energy-generating machinery. Recent evidence demonstrates that TM7x employs two ATP-generating pathways: the arginine deiminase system (ADS) and glycolysis. These ensure viability and infectivity during horizontal transmission—a critical life-cycle phase when the epibiont dissociates from its host. Notably, ammonia (NH₃) production via ADS is not merely metabolic waste but an ecological strategy to neutralize local pH, thereby protecting both TM7x and its host in acidogenic microenvironments [10,11] ((Figure 1). This retention of bioenergetic pathways suggests that TM7x is an active strategist capable of maintaining basal metabolic activity to ensure environmental persistence.

3.2. Dynamics of the Epibiotic Interaction: The TM7x Life Cycle

The relationship between N. lyticus TM7x and S. odontolytica XH001 is dynamic, progressing through stages that fundamentally alter the physiology of both partners. When TM7x is introduced to "naïve" host populations, the interaction follows a predictable trajectory from acute virulence to stable coexistence [9].

This interaction is categorized into four phases: initial encounter, death phase, recovery, and stable symbiosis. Each stage is marked by distinct shifts in gene expression and morphology (Table 1). The initial encounter involves the expression of stress-response genes in the host (basibiont) and adhesion structures in the epibiont. During the death phase, TM7x acts as a lytic epipatobiont; the host undergoes physiological shock, disrupting cell division and resulting in elongated Actinomyces cells that provide an expanded surface area for colonization. While this resembles necrotrophic parasitism, the recovery phase highlights host resilience. By diverting energy into cell-wall thickening and envelope modification, a subpopulation survives to establish an equilibrium. In this stable symbiotic stage, the relationship becomes biotrophic, allowing both organisms to thrive within a heterogeneous community [9,10] (Figure 1).

3.3. Host Range and Genomic Specificity

Host-range mapping (2020) characterized the susceptibility of Actinomyces strains to TM7x at genomic and physiological levels, revealing high host specificity [12]. This suggests that susceptibility is governed by specific genetic determinants rather than being a universal trait, reflecting prolonged co-evolution.

Physiologically, two host types are recognized:

• Permissive hosts (e.g., XH001): These exhibit a "growth-decline-recovery" response, undergoing severe initial stress and phenotypic changes before achieving symbiosis.
• Non-permissive/Resistant hosts: These allow TM7x propagation without undergoing a lytic phase or significant morphological distortions (e.g., elongation), suggesting intrinsic resistance to TM7x-induced cytopathic effects [12].

Comparative genomics indicates that permissive hosts are enriched in genes for cell-envelope glycoprotein modification (e.g., glucosamine-PI de-N-acetylase), which facilitates TM7x attachment. Conversely, resistant hosts often carry variants in surface proteins and transport systems (e.g., secA, ugpC) that may preclude effective anchoring or mitigate infection-induced stress [13].

3.4. Biofilm Modulation and AI-2 Quorum Sensing

TM7x interaction transcends the cellular scale, altering microbial community architecture. Notably, TM7x-XH001 co-cultures produce significantly denser biofilms with greater biovolume than XH001 monocultures. This modulation is mediated by the Autoinducer-2 (AI-2) quorum-sensing system [14]. In XH001, the most strongly induced gene upon association is lsrB, which encodes an AI-2 periplasmic binding protein [15]. While the lsr system in Actinomyces differs from the canonical Proteobacterial model, it acts as a master regulator of the response to TM7x. Deletion of lsrB or luxS does not prevent physical adherence but completely abrogates the symbiosis-induced increase in biofilm formation [14]. This structural reinforcement may serve as a defense mechanism against environmental stressors while simultaneously providing a stable niche for TM7x replication.

3.5. The Epibiotic Shield: Protection Against Bacteriophages

The strongest evidence for classifying TM7x as an episymbiont is its ability to shield the host from viral predation. Studies using the lytic phage LC001 showed that TM7x confers near-total phenotypic resistance to S. odontolytica XH001. This protection is multifaceted:

• Reduced Phage Adsorption: TM7x-infected cells reduce phage binding from >90% to <20%.
• Receptor Downregulation: Association with TM7x triggers the downregulation of genes involved in synthesizing cell-wall polysaccharides (CWP) and teichoic acids—the primary attachment sites for LC001.
• Population Maintenance: By protecting a host subpopulation, TM7x prevents total extinction during viral outbreaks, allowing for post-predation recovery [13].

In phage-dense oral environments [16], this "epibiotic shield" transforms a metabolic burden into a conditional mutualism.

3.6. Immunomodulation and Human Host Interaction

Historically associated with inflammatory conditions like periodontitis [4,5,17] and IBD [19], recent experimental data suggest that the role of Saccharibacteria is more nuanced.

Suppression of Pro-inflammatory Responses:

TM7x can silence host-triggered inflammatory signals. In human macrophage cultures, S. odontolytica typically induces pro-inflammatory cytokines like tumor necrosis factor alpha (TNF-α); however, this response is significantly suppressed when the host is associated with TM7x [15]. In gingival epithelial cells, TM7x uses type IV pili to induce TLR2 receptor clustering, which "dampens" signaling and reduces cytokine production in response to other pathogens. Furthermore, TM7x can be endocytosed and survive within lysosomes [21], potentially serving as a mechanism for long-term immune evasion.

In Vivo Evidence:

In murine models of periodontitis, TM7x strains significantly reduced alveolar bone loss and tissue inflammation by attenuating host pathogenicity. TM7x downregulates host genes essential for collagen degradation and sialic acid utilization [20]. Thus, TM7x may act as a stabilizing factor that tames oral pathobionts and promotes immune homeostasis.

3.7. Ecological Synthesis: Epipatobiont or Episymbiont?

The net balance of the TM7x interaction remains complex.

• The Epipatobiont Perspective: TM7x exhibits parasitic traits, including initial lethality toward naïve hosts [22], absolute nutrient dependency due to auxotrophy [1,11,12], and a numerical expansion in diseased states (up to 21% of the microbiota) [1,5].
• The Episymbiont Perspective: Cumulative evidence suggests a regulatory role. By conferring phage resistance [13], bolstering biofilms [14], and attenuating pathobiont virulence [15,20], TM7x functions as a "microbiome tamer."

These findings suggest that while TM7x is a burden at the cellular level, it provides systemic benefits that may ultimately favor the health of the mammalian host.

4. Discussion

Saccharibacteria (formerly candidate division TM7) are ubiquitous obligate epibionts whose genomes have been identified across diverse environmental and mammalian niches [1,15]. As common constituents of the human oral, vaginal, cutaneous, and intestinal microbiomes [4,15,18], their abundance often increases significantly during mucosal inflammatory diseases [4,5,15,17,19]. Consequently, this group has traditionally been classified as putative pathogens. However, due to the historical recalcitrance of TM7 to in vitro cultivation, causal research is essential to elucidate its precise role in inflammatory pathogenesis.

Nanosymbacter lyticus strain TM7x, the first cultured representative of the phylum [15], reproduces via budding. During horizontal transmission, daughter cells can dissociate from their host, S. odontolytica, to colonize new bacterial partners [22]. Recent findings by Nahar et al. (2026) [10] suggest that this phase of metabolic autonomy is supported by the combined expression of the arginine deiminase system (ADS) and glycolytic pathways for ATP generation. Nevertheless, these processes are insufficient for long-term viability, necessitating a stable association with an Actinobacterial host [15,22].

During this epiparasitic interaction, TM7x establishes a highly dynamic relationship with its host (XH001), modulated by physical attachment and environmental factors such as oxygen and nutrient availability [25]. Both partners undergo significant morphological and physiological shifts, including host cell elongation and cell-wall thickening under nutrient-rich conditions [22]. These changes are accompanied by the differential expression of over 300 genes, with those related to transport and stress responses exhibiting the highest upregulation [9,25]. As described by Bor et al. (2018) [22], the infection of a naïve host is initially characterized by an acute lytic phase—driven by an overwhelming epibiont load (exceeding 50 cells per host)—followed by the rapid development of reduced host susceptibility and the establishment of long-term stable symbiosis (Figure 1). This transition is hypothesized to result from rapid host evolution; genomic sequencing of stable lineages has revealed multiple mutations in transporter and regulatory genes that potentially confer partial protection against lethal infection [22].

The dual nature of N. lyticus TM7x reflects an ecological adaptation common among obligate symbionts with reduced genomes. In the volatile oral environment, where bacterial hosts face pressure from viral predation, antibiotics, and the immune system, association with an epibiont may constitute a vital survival strategy. This relationship can be interpreted through the lens of kin selection or community-level benefit: while individual cells may perish during initial infection [22], the resulting population achieves greater resilience and stability within the biofilm [15]. Furthermore, Dong et al. (2024) [26] demonstrated that TM7x infection induces the formation of host lipid droplets under environmental stress, potentially enabling S. odontolytica to withstand oxidative challenges [26,27]. Additionally, the capacity of TM7x to modulate human immune signaling suggests that Saccharibacteria have evolved not only to exploit their bacterial hosts but also to protect the shared ecological niche from excessive inflammatory destruction [14,15,20].

While substantial evidence links increased Saccharibacteria levels—up to 21% of the microbiota—to periodontal inflammation [2,3,22], a recent study by Bachtiar et al. (2024) [28] challenges this paradigm. Comparing subjects with type 2 diabetes with and without periodontitis, the authors found that TM7 abundance was significantly lower in the diabetic periodontitis group, while remaining elevated in healthy and gingivitis subjects. Notably, only in diabetic patients with periodontitis did the TM7-to-S. odontolytica ratio show an inverse correlation with subgingival biofilm and C-reactive protein transcript levels. These findings contest the role of TM7 as a universal predictor of periodontitis. However, the study's limitations—including a small sample size, lack of longitudinal glucose monitoring, and the measurement of total TM7 rather than specific strains like TM7x—must be considered. Given the high genotypic variability within the TM7 lineage [29], ecological responses are likely strain-specific.

Collectively, preclinical and clinical data [20,21,28] suggest that Saccharibacteria may not be direct drivers of inflammation. Instead, their expansion may represent an ecological response to host (Actinobacteria) abundance or a systemic attempt to mitigate the virulence of "red complex" pathobionts through indirect interactions. This perspective shifts the clinical interpretation of these organisms, suggesting their potential future use as probiotics or replacement therapy agents to restore homeostasis in chronic periodontal disease.

In summary, the oral ecology of N. lyticus TM7x involves two distinct stages: a transient individual stage of independent survival—insufficient for persistence—followed by the defining stage of epibiosis. This latter stage encompasses an initial parasitic phase that triggers host mortality, transitioning into a stable coexistence where the host gains adaptive advantages while the epibiont achieves robust replication via budding (Figure 2).

5. Conclusions

A systematic synthesis of the experimental and clinical evidence to date indicates that N. lyticus strain TM7x functions primarily as a regulatory episymbiont within the human oral ecosystem. Although it retains an initial pathogenic phase in naïve hosts—technically characterizing it as an obligate parasite—its long-term integration into the microbiome facilitates significant mutualistic benefits that enhance ecological stability and host immune protection.

This organism has transitioned from being regarded as "biological dark matter" to serving as a pivotal model for understanding coevolution within the human microbiome. Its capacity to shield the host from viral predation, induce structurally robust biofilms, and attenuate destructive inflammatory responses positions TM7x as a vital component of the oral homeostatic network.

6. Future Perspectives

The findings synthesized in this review underscore the multifaceted role of N. lyticus TM7x and highlight several critical avenues for future research:

Mechanisms of Horizontal Transmission: Further investigation is required to elucidate how the Arginine Deiminase System (ADS) and glycolytic pathways synergistically maintain TM7x infectivity and metabolic resilience within the competitive and chemically dynamic salivary environment. Understanding these bioenergetic strategies is essential to map the transmission bottlenecks of epibionts in the human microbiome.

Probiotic Engineering and Biotherapy: Future studies should evaluate the feasibility of utilizing specific Saccharibacteria strains as Next-Generation Probiotics (NGPs). Harnessing these epibionts as biological therapies could offer a novel approach to modulating the virulence of oral pathobionts and restoring microbial homeostasis in patients with chronic inflammatory diseases.

Molecular Determinants of Host Specificity: Identifying the specific molecular signatures on the Actinomyces cell envelope that dictate "permissiveness" is a priority. Deciphering these host-epibiont recognition codes could enable the development of targeted ecological engineering strategies, using specific epibionts to selectively control or "tame" bacterial populations within complex oral biofilms.